"Metoclopramide" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A dopamine D2 antagonist that is used as an antiemetic.
| Descriptor ID |
D008787
|
| MeSH Number(s) |
D02.065.277.573 D02.241.223.100.050.500.647 D02.241.223.100.100.510 D02.241.223.100.200.750 D02.241.223.100.300.350.625 D02.241.511.390.350.625 D02.455.426.559.389.127.020.937.647 D02.455.426.559.389.127.085.510 D02.455.426.559.389.127.250.750 D02.455.426.559.389.127.281.350.625 D02.455.426.559.389.657.654.638.625
|
| Concept/Terms |
Metoclopramide- Metoclopramide
- 4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide
- Metaclopramide
Metoclopramide Hydrochloride- Metoclopramide Hydrochloride
- Hydrochloride, Metoclopramide
- Metoclopramide Monohydrochloride
- Monohydrochloride, Metoclopramide
- Metoclopramide Monohydrochloride, Monohydrate
|
Below are MeSH descriptors whose meaning is more general than "Metoclopramide".
Below are MeSH descriptors whose meaning is more specific than "Metoclopramide".
This graph shows the total number of publications written about "Metoclopramide" by people in this website by year, and whether "Metoclopramide" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 1 | 0 | 1 |
| 1999 | 0 | 1 | 1 |
| 2002 | 1 | 0 | 1 |
| 2005 | 0 | 2 | 2 |
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 1 | 2 |
| 2013 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Metoclopramide" by people in Profiles.
-
The metoclopramide black box warning for tardive dyskinesia: effect on clinical practice, adverse event reporting, and prescription drug lawsuits. Am J Gastroenterol. 2013 Jun; 108(6):866-72.
-
A randomized open-label study of sodium valproate vs sumatriptan and metoclopramide for prolonged migraine headache. Am J Emerg Med. 2013 Mar; 31(3):540-4.
-
The use of olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy. Support Care Cancer. 2013 Jun; 21(6):1655-63.
-
Metoclopramide versus hydromorphone for the emergency department treatment of migraine headache. J Pain. 2008 Jan; 9(1):88-94.
-
Prevention of emesis from multiple-day and high-dose chemotherapy regimens. J Natl Compr Canc Netw. 2007 Jan; 5(1):51-9.
-
Acute chorea associated with metoclopramide use. Am J Ther. 2006 Nov-Dec; 13(6):543-4.
-
Persistent hiccups after attempted interscalene brachial plexus block. Reg Anesth Pain Med. 2005 Nov-Dec; 30(6):574-6.
-
[Dopaminergic and somatostatinergic pathways decrease serum thyrotropin in rats bearing the 256-Walker mammary carcinoma]. Arq Bras Endocrinol Metabol. 2005 Apr; 49(2):253-64.
-
Cardiac arrest after labetalol and metoclopramide administration in a patient with scleroderma. Anesth Analg. 2002 Dec; 95(6):1667-8, table of contents.
-
Use of placebos in delayed-emesis studies. J Clin Oncol. 1999 May; 17(5):1648-50.